Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Depressants01:28

Depressants

Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Structural Mass-Spectrometric Description of Immune Complexes in Vaccine-Induced Immune Thrombocytopenia and Thrombosis.

Journal of the American Chemical Society·2026
Same author

Adenoviral Inciting Antigen and Somatic Hypermutation in VITT.

The New England journal of medicine·2026
Same author

Shared molecular profiles of anti-PL12 autoantibodies in anti-synthetase syndrome.

Rheumatology (Oxford, England)·2025
Same author

Anti-PF4 mediated thrombocytopenia and thrombosis associated with acute cytomegalovirus infection displays both HIT-like and VITT-like characteristics.

British journal of haematology·2025
Same author

VITT-like Monoclonal Gammopathy of Thrombotic Significance.

The New England journal of medicine·2025
Same author

A triad of somatic mutagenesis converges in self-reactive B cells to cause a virus-induced autoimmune disease.

Immunity·2025

関連する実験動画

Updated: Jul 7, 2026

A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training
07:50

A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training

Published on: January 29, 2017

ナルコレプシーにおける機能的な自己抗体.

Anthony J F Smith1, Michael W Jackson, Petra Neufing

  • 1Department of Immunology, Allergy and Arthritis, Flinders Medical Centre, Bedford Park, SA 5042, Australia.

Lancet (London, England)
|December 14, 2004
PubMed
まとめ

研究者らは,ナルコレプシーの潜在的自己免疫マーカーを発見した. ナルコレプシー患者からの免疫グロブリンGは膀の筋肉の反応を強め,ナルコレプシー-カタプレキシの自己免疫的基礎を支持しました.

科学分野:

  • 神経免疫学 神経免疫学とは
  • 自己免疫性疾患は自己免疫性疾患である.
  • 睡眠障害 睡眠障害

背景:

  • ナルコレプシーは自己免疫的であると疑われるが,特定の血清自己抗体マーカーは依然として難解である.
  • コリン性多動性 (Cholinergic hyperactivity) は,ナルコレプシー・カタプレキシの既知の特徴である.

研究 の 目的:

  • 患者に由来するIgGの機能的効果を調べることで,ナルコレプシーの自己免疫的基礎を調査する.
  • ナルコレプシー-カタプレキシに寄与する潜在的な自己抗体を特定する.

主な方法:

  • 免疫グロブリンG (IgG) は9人のナルコレプシー患者と9人の健康な対照群から分離されました.
  • IgGは,滑らかな筋肉の収縮反応への影響を評価するためにマウスに移植されました.
  • 反応は,特にカルバコールとニューロンから放出されたアセチルコリンを使用して,コリナージック刺激の後に測定されました.

主要な成果:

  • すべてのナルコレプシー患者からのIgGは,コントロールIgG (p<0.0001) と比較して,コレリン活性アゴニストに対する膀収縮反応を著しく強化しました.
  • 補強は膀に特異的であり,同情的に内蔵された精管の収縮は変化しなかった.
  • これは,膀内のコレリン作用経路に影響を与える特定の自己免疫メカニズムを示唆しています.

さらに関連する動画

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

関連する実験動画

Last Updated: Jul 7, 2026

A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training
07:50

A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training

Published on: January 29, 2017

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

結論:

  • この発見は,ナルコレプシーの自己免疫性仮説を支持する直接的な証拠を提供します.
  • ナルコレプシーにおける特定の自己抗体マーカーは,コレリン反応経路を標的にし,カタプレキシのような症状を引き起こす可能性があります.
  • この研究は,ナルコレプシーの診断と治療戦略に新しい道を開きます.